SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 31 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $429,000 | -45.6% | 72,588 | -57.6% | 0.00% | – |
| Q4 2020 | $789,000 | +45.3% | 171,190 | +22.7% | 0.00% | – |
| Q3 2020 | $543,000 | -53.6% | 139,473 | +156.9% | 0.00% | -100.0% |
| Q1 2020 | $1,169,000 | +10.1% | 54,296 | +0.6% | 0.00% | 0.0% |
| Q4 2019 | $1,062,000 | -77.1% | 53,970 | -82.5% | 0.00% | -75.0% |
| Q3 2019 | $4,632,000 | – | 308,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 3,096,729 | $21,832,000 | 7.61% |
| Ghost Tree Capital, LLC | 904,225 | $6,375,000 | 1.75% |
| RA Capital Management | 5,914,252 | $41,695,000 | 0.67% |
| Vivo Capital, LLC | 1,232,394 | $8,688,000 | 0.38% |
| Ikarian Capital, LLC | 644,056 | $4,540,000 | 0.37% |
| NEA Management Company, LLC | 3,142,958 | $22,158,000 | 0.29% |
| SAMLYN CAPITAL, LLC | 1,583,889 | $11,166,000 | 0.16% |
| Monashee Investment Management LLC | 118,027 | $832,000 | 0.10% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $13,296,000 | 0.10% |
| Tibra Equities Europe Ltd | 35,000 | $247,000 | 0.08% |